SB0781

2013 Regular Session

 

Entitled:

Pharmacists - Biosimilar Biological Products - Substitutions

Sponsored by:

Senator Conway

Status:

In the House - Hearing 4/04 at 1:00 p.m.


Document Name
Amendments Senate - (Education, Health, and Environmental Affairs) {124936/01 Adopted
Analysis - Fiscal and Policy Note (Revised)
Text - First - Pharmacists - Biosimilar Biological Products - Substitutions
Text - Third - Pharmacists - Biosimilar Biological Products - Substitutions
Vote - Senate - Committee - Education, Health, and Environmental Affairs
Vote - Senate Floor - Third Reading Passed (46-1) - 03/13/13


Documents become available at various times as the legislation moves through the General Assembly.

  • First reading text - within 24 hours of introduction.
  • Analysis (Fiscal and Policy Note) and the Bond Authorization Fact Sheet - generally at least one day prior to a scheduled hearing.
  • Committee votes - when the Committee releases their report.
  • Committee amendments and individually sponsored amendments - when introduced in the chamber.
  • Conference Committee reports and amendments - when the report is introduced in the chamber.
  • Floor Votes - when they have been officially journalized by the Secretary of the Senate or House Clerk.
  • Attorney General's Bill Review Letter - after legislation is passed.

How a Bill Becomes Law

Legislative Lingo

Explanation of Floor Motions and Actions


October 29, 2013 10:11 P.M.